Immune response results in the proliferation of self-autoreactive B cells and formation of GC in the white pulp, with the spleen index apparently increased. harvested for histopathological examination. Spleen index and thymus index were calculated. The levels of BLyS, interleukin (IL)-17, interferon (IFN)-, IgG1, IgG2a and IgM in AA rat spleen were measured by enzyme-linked immunosorbent assay. Administration of TACI-Ig significantly reduced the arthritis global assessment and SJC, decreased spleen index and ameliorated histopathological manifestations of rat AA. Suppressing the levels of BLyS, IL-17, Resminostat IFN- and Ig in AA rat spleen were observed after administration of TACI-Ig. These results showed that TACI-Ig significantly inhibited the degree of rat AA, and the inhibitory effects might be associated with its ability to reduce BLyS, proinflammatory cytokines and Ig levels in spleen. Keywords:adjuvant arthritis, immunoglobulin, pro-inflammatory cytokine, spleen, TACI-Ig == Introduction == Rheumatoid arthritis (RA) is usually a chronic disorder that mainly targets the synovial membrane of joints but can also have systemic manifestations [1]. The disease is usually characterized by synovial membrane hyperplasia and infiltration of inflammatory cells, including activated B cells. Although it has long been considered a T cell/macrophage-driven pathology, the success of B cell-targeted therapies (for Resminostat example, rituximab) in the treatment of RA patients has led investigators to reassess the crucial role of B cells in RA pathogenesis [24]. It is now established that B cells have many more functions in RA than simply producing autoantibodies (rheumatoid factor, anti-cyclic citrullinated proteins, and so on); B cells are also potent antigen-presenting cells (APC) and play a critical role in the activation of T cells in the synovium of RA. Furthermore, B cells not only respond to but also produce proinflammatory cytokines such as tumour necrosis factor (TNF)-[58]. Thus, B cells have emerged as rational targets Mouse monoclonal to CD45RA.TB100 reacts with the 220 kDa isoform A of CD45. This is clustered as CD45RA, and is expressed on naive/resting T cells and on medullart thymocytes. In comparison, CD45RO is expressed on memory/activated T cells and cortical thymocytes. CD45RA and CD45RO are useful for discriminating between naive and memory T cells in the study of the immune system for new drug development in RA. B lymphocyte stimulator (BLyS; trademark of Human Genome Sciences, Rockville, MD, USA) is also called BAFF, THANK, TALl-1, TNFSF13b and zTNF4. This cytokine is usually shown to be a key regulator of B cell maturation, proliferation and survival, and is an identified 285-amino acid member of the TNF ligand superfamily. BLyS is usually expressed by a few stromal cells, T cells and most myeloid cell lineages, including monocytes, macrophages, dendritic cells and stimulated neutrophils [9,10]. A proliferation-inducing ligand (APRIL), also called TNFSF13a, is usually another TNF family member that is closely related to BLyS [11,12]. Three TNF receptor-related receptors have been identified that have unique binding affinities for BLyS and APRIL: transmembrane activator or calcium-modulating cyclophylin ligand-interactor (TACI), B cell maturation antigen (BCMA) and B cell activating factor receptor (BAFF-R). TACI and BCMA bind both BLyS and APRIL, while BAFF-R appears to bind only BLyS with high affinity [13,14]. TACI is usually expressed not only on mature B cells but also on activated T cells, which suggests that BLyS and APRIL may also regulate T cell-mediated immune functions [15]. Mounting evidence from human and animal models supports an Resminostat important role of BLyS and APRIL in the development of autoimmune disease. Over-expression of BLyS in BLyS-transgenic mice results in B cell hyperplasia, hypergammaglobulinaemia and development of autoimmune-like disease [13,16]. Similarly, over-expression of BLyS accelerates B6.Sle1.BAFF and B6.Nba2.BAFF mice develop a lupus-like phenotype consisting of anti-double-stranded DNA (anti-dsDNA) antibodies and immunoglobulin (Ig) deposition in the kidneys [17]. In addition, circulating heterotrimer complexes of BLyS and APRIL have been identified in serum from patients with rheumatic diseases [18]. Elevated BLyS and APRIL levels are found in serum and in synovial fluid of patients with RA and systemic lupus erythematosus (SLE), and the levels of BLyS and APRIL are higher in RA synovial fluid than in blood, particularly in the presence of significant joint inflammation, suggesting that these ligands may play an important role in the inflamed synovial compartment [1921]. The above-mentioned compelling observations in human and animal models have led.